Free Trial

OptimizeRx (OPRX) Insider Trading & Ownership

OptimizeRx logo
$4.87 +0.38 (+8.46%)
(As of 11/22/2024 ET)

OptimizeRx (NASDAQ:OPRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$60,760.00
Get OPRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling OptimizeRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OPRX Insider Buying and Selling by Quarter

OptimizeRx Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/9/2024Marion Odence-FordGeneral CounselSell4,000$15.19$60,760.00  
(Data available from 1/1/2013 forward)

OPRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at OptimizeRx includes Edward Stelmakh, Ellen O'connor Vos, James Paul Lang, Marion Odence-Ford, Miriam J Paramore, Stephen L Silvestro, and William J Febbo. Learn more on insiders at OPRX.

6.10% of OptimizeRx stock is owned by insiders. Learn more on OPRX's insider holdings.

The following insider sold OPRX shares in the last 24 months: Marion Odence-Ford ($60,760.00).

Insiders have sold a total of 4,000 OptimizeRx shares in the last 24 months for a total of $60,760.00 sold.

OptimizeRx Key Executives



This page (NASDAQ:OPRX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners